EUVIMEDEUVIMED entdecken
Crossref

Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy

J S E Quik, J W van Sandick, E C Owers, A Bartels-Rutten, F E M Voncken, L L Kodach iD, T R de Wijkerslooth, J M van Dieren, J E G IJspeert

Diseases of the Esophagus · 02.11.2026 · 39 (6)

DOI: 10.1093/dote/doag128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 03.11.2026. Verfasst von J S E Quik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Staging, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Esophagogastric Junction. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic ultrasonography with fine-needle aspiration (EUS(-FNA)) is recommended by current guidelines as part of the staging for esophageal and gastro-esophageal junction (GEJ) carcinoma, yet its incremental value over modern 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) remains uncertain. This Lessons Learned article reflects on over a decade of EUS(-FNA) and FDG-PET staging in 402 patients with potentially curable esophageal or GEJ carcinoma at a high-volume tertiary referral center. In 91.3% of patients, EUS(-FNA) did not alter the radiation field as would have been defined by FDG-PET. EUS(-FNA) resulted in an expansion of the radiation field in 4.5% and reduction in 4.2% of patients. Squamous cell carcinoma showed more than two-fold greater likelihood of radiation field modification. Among 193 patients classified as FDG-PET non-suspicious for malignant lymph nodes (LNs), EUS-FNA identified malignant LNs in eight patients (4.1%), which influenced the radiation field. In 5 of 402 patients (1.2%) a malignant LN was detected with EUS-FNA in a station that would not have routinely been resected surgically. In patients planned for neoadjuvant or definitive chemoradiotherapy (CRT), LN staging is of direct therapeutic consequence: underestimation of nodal disease may result in geographic miss, while overestimation leads to unnecessary irradiation. In contrast, in patients treated with perioperative 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) followed by surgical lymphadenectomy, most involved LN stations are routinely addressed surgically, limiting the added value of EUS(-FNA) for treatment planning. Therefore, we view EUS(-FNA) as a selective staging tool in patients planned for neoadjuvant or definitive CRT, rather than a procedure applied routinely to all patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoplasm StagingEndoscopic Ultrasound-Guided Fine Needle AspirationEsophagogastric JunctionCarcinoma, Squamous CellHumansPositron-Emission TomographyLymphatic MetastasisFluorodeoxyglucose F18FemaleLymph NodesRadiopharmaceuticalsMaleAgedMiddle AgedEndosonography

Stichwörter der Autor:innen

FDG-PET-CTchemoradiotherapyendoscopic ultrasonographyesophageal cancerradiation fieldstaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Gastrointestinal Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.

ORCID-Profile: L L Kodach

Zitieren

APA

Quik, J. S. E., van Sandick, J. W., Owers, E. C., Bartels-Rutten, A., Voncken, F. E. M., Kodach, L. L., de Wijkerslooth, T. R., van Dieren, J. M., & IJspeert, J. E. G. (2026). Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy. Diseases of the Esophagus, 39(6). https://doi.org/10.1093/dote/doag128

Vancouver

Quik JSE, van Sandick JW, Owers EC, Bartels-Rutten A, Voncken FEM, Kodach LL, et al. Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy. Diseases of the Esophagus. 2026;39(6). doi:10.1093/dote/doag128

BibTeX
@article{Quik2026,
  author = {Quik, J S E and van Sandick, J W and Owers, E C and Bartels-Rutten, A and Voncken, F E M and Kodach, L L and de Wijkerslooth, T R and van Dieren, J M and IJspeert, J E G},
  title = {Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy},
  journal = {Diseases of the Esophagus},
  year = {2026},
  volume = {39},
  number = {6},
  doi = {10.1093/dote/doag128}
}
Kostenlos starten →